Related Experiment Video
Updated: May 12, 2026
08:34
Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
Published on: February 6, 2019
Hypofractionated external-beam radiotherapy for prostate cancer
L Chinsoo Cho1, Robert Timmerman, Brian Kavanagh
1University of Minnesota Medical Center, 420 Delaware Street SE, MMC-494, Minneapolis, MN 55455, USA.
Prostate Cancer
|March 28, 2013
Summary
Hypofractionated radiotherapy shows promise for prostate cancer treatment. Advanced techniques enable shorter radiation programs with successful outcomes and no increase in late side effects.
Area of Science:
- Radiation Oncology
- Medical Physics
Background:
- Radiobiological principles support hypofractionated radiotherapy for prostate cancer.
- Advancements in radiation treatment planning and delivery are crucial.
Purpose of the Study:
- To evaluate the efficacy and safety of hypofractionated radiotherapy for localized prostate cancer.
Main Methods:
- Utilizing sophisticated radiation treatment planning and delivery systems.
- Leveraging radiobiological differences between prostate cancer and surrounding normal tissues.
Main Results:
- Preliminary clinical studies indicate successful treatment of localized prostate cancer.
- Abbreviated fractionation programs did not escalate late toxicity.
Conclusions:
- Hypofractionated radiotherapy is a viable option for localized prostate cancer.
- Advanced technology facilitates effective and safe abbreviated radiation courses.
